Form D/A — Magnus Medical, Inc.
0002057312-26-000002 · filed May 26, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $77,000,000
- Reported amount sold
- $49,030,035
- Minimum investment
- $0
- Investors
- 10
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Magnus Medical, Inc.
- CIK
- 2057312
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1350 OLD BAYSHORE HWY, SUITE 600
BURLINGAME, CA 94010 - Phone
- (415) 231-7407
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Achal Achrol · Executive OfficerBurlingame, CA Find on LinkedIn ↗
-
Andrew Firlik · DirectorBurlingame, CA Find on LinkedIn ↗
-
Heath Lukatch · DirectorBurlingame, CA Find on LinkedIn ↗
-
Brandon Bentzley · Executive OfficerBurlingame, CA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗